KIN-4104

N/A

Report date: 2025/01/26 18:31:36

NME

Base Information

Drug NameKIN-4104

Drug Alias Namepan flt aurora kinase inhibitor (Kinentia)KIN-4104

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionFibroblast growth factor receptor 1 antagonistsTyrosine-protein kinase receptor FLT3 inhibitorsVascular endothelial growth factor receptor 1 antagonists +[4]

TargetsVascular endothelial growth factor receptor 1Fibroblast growth factor receptor 1Tyrosine-protein kinase receptor FLT3 +[4]

Therapy Area/IndicationsLeukemia, Myeloid, Acute

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesKinentia Biosciences Llc

China Registration ClassN/A

Develop Information

Active CompaniesKinentia Biosciences Llc

Inactive CompaniesN/A

Active IndicationsLeukemia, Myeloid, Acute

Inactive IndicationsN/A

Other Information

ATC CodeN/A